30 months relapse-free survival, overall survival, and long-term toxicity update of (neo)adjuvant ipilimumab (ipi) + nivolumab (nivo) in macroscopic stage III melanoma (OPACIN trial)
Titel:
30 months relapse-free survival, overall survival, and long-term toxicity update of (neo)adjuvant ipilimumab (ipi) + nivolumab (nivo) in macroscopic stage III melanoma (OPACIN trial)
Auteur:
Rozeman, E.A. Sikorska, K. van de Wiel, B.A. Fanchi, L.F. Krijgsman, O. van Thienen, H.V. Pronk, L.M. Broeks, A. Grijpink-Ongering, L. Ter Meulen, S. Bruining, A. Klop, W.M.C. van Tinteren, H. Peeper, D. Haanen, J.B.A.G. van Akkooi, A.C.J. Schumacher, T.N. Blank, C.U.